Bandhan BSE Healthcare Index Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.22%)Nav, as on 25-02-2025

  • Previous Nav

  • Net Change on 25-02-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI -6.61 -9.15 10.67 19.98 23.65 15.26

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 6.33 18.76 23.68 1.82 8,160.74
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 13.66 22.88 26.21 1.93 4,917.81
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 12.23 22.81 24.70 1.94 3,521.93
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 12.32 20.93 25.06 1.91 3,197.52
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 9.20 17.16 23.60 1.94 2,652.24

Fund Holdings as on 31-January-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Max Healthcare Institute Limited

  • Dr. Reddy's Laboratories Limited

  • Divi's Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • Lupin Limited

  • Fortis Healthcare Limited

  • Aurobindo Pharma Limited

  • Torrent Pharmaceuticals Limited

  • Alkem Laboratories Limited

  • Mankind Pharma Limited

  • Zydus Lifesciences Limited

  • Laurus Labs Limited

  • Glenmark Pharmaceuticals Limited

  • IPCA Laboratories Limited

  • Biocon Limited

  • Krishna Institute Of Medical Sciences Limited

  • Piramal Pharma Limited

  • Syngene International Limited

  • Suven Pharmaceuticals Limited

  • Abbott India Limited

  • Concord Biotech Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Neuland Laboratories Limited

  • Gland Pharma Limited

  • Ajanta Pharma Limited

  • Wockhardt Limited

  • Aster DM Healthcare Limited

  • Dr. Lal Path Labs Limited

  • Natco Pharma Limited

  • Narayana Hrudayalaya Limited

  • Poly Medicure Limited

  • Global Health Limited

  • Granules India Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Jubilant Pharmova Limited

  • Rainbow Childrens Medicare Limited

  • Pfizer Limited

  • Jupiter Life Line Hospitals Limited

  • Ami Organics Limited

  • Eris Lifesciences Limited

  • Alembic Pharmaceuticals Limited

  • Sanofi India Limited

  • Marksans Pharma Limited

  • Vijaya Diagnostic Centre Limited

  • Metropolis Healthcare Limited

  • Strides Pharma Science Limited

  • AstraZeneca Pharma India Limited

  • Procter & Gamble Health Limited

  • Caplin Point Laboratories Limited

  • Shilpa Medicare Limited

  • Alivus Life Sciences Limited

  • Indegene Limited

  • Aarti Pharmalabs Limited

  • Kovai Medical Center and Hospital Limited

  • FDC Limited

  • Morepen Laboratories Limited

  • Orchid Pharma Limited

  • Healthcare Global Enterprises Limited

  • Indraprastha Medical Corporation Limited

  • Sequent Scientific Limited

  • Supriya Lifescience Limited

  • Blue Jet Healthcare Ltd

  • Sun Pharma Advanced Research Company Limited

  • Advanced Enzyme Technologies Limited

  • Innova Captab Limited

  • Krsnaa Diagnostics Limited

  • Solara Active Pharma Sciences Limited

  • Dishman Carbogen Amcis Limited

  • Unichem Laboratories Limited

  • Aarti Drugs Limited

  • Triparty Repo TRP_030225

  • Hikal Limited

  • Thyrocare Technologies Limited

  • Gufic Biosciences Limited

  • Yatharth Hospital And Trauma Care Services Limited

  • RPG Life Sciences Limited

  • Bliss GVS Pharma Limited

  • Gujarat Themis Biosyn Limited

  • Indoco Remedies Limited

  • Artemis Medicare Services Limited

  • Syncom Formulations India Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • Suven Life Sciences Limited

  • Sigachi Industries Limited

  • Hester Biosciences Limited

  • Windlas Biotech Limited

  • Lincoln Pharmaceuticals Limited

  • Themis Medicare Limited

  • Vimta Labs Limited

  • Shalby Limited

  • SMS Pharmaceuticals Limited

  • Tarsons Products Limited

  • Novartis India Limited

  • Kopran Limited

  • GPT Healthcare Limited

  • NGL Fine Chem Limited

  • KMC Speciality Hospitals (India) Limited

  • Sastasundar Ventures Limited

  • Cash Margin - CCIL

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Chemicals

  • Plastic Products

  • Trading

  • Finance - NBFC

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About Bandhan BSE Healthcare Index Fund

Scheme Analysis

Bandhan BSE Healthcare Index Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Bandhan Mutual Fund. It was launched on 06-Sep-2024 and currently has an AUM of ₹17.29 crore. Bandhan BSE Healthcare Index Fund is benchmarked against BSE Health Care - TRI as primary index.

The NAV of Bandhan BSE Healthcare Index Fund ended down ₹-0.02(-0.22%)yesterday to ₹9.0218.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Bandhan BSE Healthcare Index Fund is managed by Nemish Sheth .

Fund House Contact

6th Floor, One World Centre, 841, Jupiter Mills Compound, Senapati Bapat Marg, Elphinstone Road (West), Mumbai - 400 013

022-66289999
022-24215052